Is The Biotech Sector Stuck In A Talent Time-Loop?
This article was originally published in Scrip
Executive Summary
Recently Scrip took an in depth look at the lack of female board members and senior executives at pharmaceutical and biotech companies – and the data showed a shocking gender gap at the top of these businesses. Diversity issues for boards of life science companies appear not to be limited to gender inequality, either.
You may also be interested in...
Six New Molecules By 2030 – J&J’s Neuroscience Strategy
Can neuroscience be precise? Peter Fang, worldwide VP of neuroscience, explains J&J's approach to precision medicine in Alzheimer’s disease, depression and other neurological conditions.
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.